Healthcare

Intravenous Infusion Pumps Market Size to Reach US$ 10.4 billion by 2030

The global Intravenous Infusion Pumps market size is expected to be worth around US$ 10.4 billion by 2030, according to a new report by Vision Research Reports.

Intravenous Infusion Pumps Market (By Product: Infusion pumps; By Disease Indication: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38311

Report Highlights

The insulin infusion pumps are anticipated to witness a CAGR of 9.5% over the forecast period. On the basis of product, the market is segmented into volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps.

According to the International Diabetes Federation (IDF), nearly 563 million adults were living with diabetes across the globe in 2020 and this number is anticipated to reach 800 million by 2045. With the growing prevalence of diabetes, devices such as insulin infusion pumps come in handy for people who self-administer insulin on daily basis.

The Paediatrics/Neonatology segment was identified as the largest segment with 37.0% revenue share in 2020 followed by gastroenterology. On the basis of disease indication, the market has been segmented into chemotherapy diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and others.

Neonatology is a branch of medicine that deals with infants born in/with acute conditions, including prematurity, low birth weight, intrauterine growth restriction, congenital malformations (birth defects), sepsis, pulmonary hypoplasia, or birth asphyxia. According to WHO, 15 million babies are born preterm, which is a leading cause of newborn deaths in the world. The number of babies born preterm can be reduced by nearly three quarters with feasible, cost-effective care and proper nutrition in the initial stages after birth.

North America dominated the intravenous infusion pumps market and accounted for the largest revenue share of 59.3% in 2020. The segment is expected to maintain its growth rate over the forecast period. This can be attributed mainly to factors such as developed medical infrastructure, high chronic disease burden, and advancements in infusion technology. Moreover, factors such as favorable insurance and medical device reimbursement policies, strong local presence of key manufacturers, and major exporters of intravenous infusion pumps are likely to propel the regional market over the coming years.

Key Players

  • Baxter International
  • B. Braun Melsungen AG
  • Medtronic
  • Micrel Medical Devices SA
  • Boston Scientific Corporation
  • CareFusion Corporation
  • Fresenius Kabi
  • Smiths Medical

Market Segmentation

  • Product Outlook
    • Infusion pumps
      • Volumetric Infusion pumps
      • Insulin Infusion pumps
      • Syringe Infusion pumps
      • Enteral Infusion pumps
      • Ambulatory Infusion pumps
      • Patient-Controlled Analgesia Infusion Pumps
      • Implantable Infusion pumps
      • Others
  • Disease Indication Outlook
    • Chemotherapy
    • Diabetes
    • Gastroenterology
    • Analgesia/Pain Management
    • Pediatrics/Neonatology
    • Hematology
    • Others
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Netherlands
      • Belgium
      • Switzerland
      • Russia
      • Sweden
    • Asia Pacific
      • India
      • Japan
      • China
      • Australia
      • South Korea
      • Malaysia
      • Singapore
      • New Zealand
      • Philippines
      • Thailand
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Egypt

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38311

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Intravenous Infusion Pumps Market, By Product

7.1.  Intravenous Infusion Pumps Market, by Product, 2021-2030

7.1.1.    Infusion pumps

7.1.1.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Intravenous Infusion Pumps Market, By Disease Indication

8.1.  Intravenous Infusion Pumps Market, by Disease Indication, 2021-2030

8.1.1.    Chemotherapy

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Diabetes

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Gastroenterology

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Analgesia/Pain Management

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Pediatrics/Neonatology

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Hematology

8.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Intravenous Infusion Pumps Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2016-2030)

9.1.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2016-2030)

9.2.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2016-2030)

9.3.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2016-2030)

9.4.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2016-2030)

9.5.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

Chapter 10.  Company Profiles

10.1.              Baxter International

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              B. Braun Melsungen AG

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Medtronic

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Micrel Medical Devices SA

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Boston Scientific Corporation

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              CareFusion Corporation

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Fresenius Kabi

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Smiths Medical

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38311

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button